DRUGS/HEALTHCARE/TRUMP EXECUTIVE ORDERS: “It is the policy of the United States to enable Americans without access to affordable insulin and injectable epinephrine through commercial insurance or Federal programs, such as Medicare and Medicaid, to purchase these pharmaceuticals from an FQHC at a price that aligns with the cost at which the FQHC [Federally Qualified Health Centers] acquired the medication.”
-Donald Trump, “Access to Affordable Life-Saving Medications,” govinfo.gov, July 24, 2020
[Note: Read the full Executive Order signed by Donald Trump.]